Simple and Accessible
Stratford Management WHAT WE DO
Why Choose Us
We have a reputation for hiring and fostering the industry’s top talent to support our company mission. Our teams include people from a variety of professional backgrounds with many having 20+ year careers in the industry.
At Stratford Management, people are at the heart of everything we do. Our management team takes great pride in inspiring a positive work environment, encouraging team collaboration and giving every individual the proper balance of support and autonomy to learn the necessary skills to do the best for our clientele.
We firmly believe that by giving employees all needed support, they will inherently become strong performers in the marketplace. We invest in leading products and services for our employees and their clients.
A firm advocate of equal opportunity, Stratford Management employs people from all backgrounds to work with our international client base. Our staff are trained to understand the nuances of different cultures, ensuring all clients are treated with respect.
More than 25 Years
Informed Investment Decisions
With Stratford Management, you receive comprehensive support to ensure the best possible results for your investment strategy. Your personal Stratford Management advisor will base decisions on the investment plan tailored to meet your specific needs. Long-term relationships built on trust are the foundation of our financial services.
We Are Hiring
We are always on the look out for motivated, dedicated and talented colleagues. We offer an inspiring, international environment and a wide range of opportunities. The long-term outlook we take with our clients extends to our employees. Motivated and engaged people are our greatest strength and key to our success.
Our reputation precedes us. Here is what clients are saying.
“Thank you for everything. In addition to the wisdom and helpful financial guidance, the time you take explaining things give me a better understanding of what’s happening in the world.”
“At Stratford, they take time to really listen and understand your life experience before offering guidance and feedback. They’re careful, methodical and systematic in their approach. Common sense is not so common.”
“My wife and I enjoy our annual portfolio review. We feel confident about where we’re headed. We understand the rationale behind all of our investments. We feel secure knowing you’re watching over our portfolio.”
Request a Call Back.
News Updates 24/7
(RTTNews) – Belden Inc. (BDC), a supplier of specialty networking solutions, on Wednesday reported attributable net income for the third quarter of $17.00 million or $0.38 per share, compared to net loss of $297.98 million or $6.70 per share in the year-ago period. Adjusted earnings for the quarter were $0.72 per share, compared to $1.19 per share in the prior-year quarter. Revenues for the quarter declined to $475.8 million from $533.1 million in the prior-year period. On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.61 per share for the quarter on revenues of $445.78 million. Analysts’ estimates typically exclude special items. Looking ahead to the fourth quarter, Belden expects adjusted earnings in a range of $0.63 to $0.78 per share and revenues in a range of $460 million to $485 million. The Street expects earnings of $0.80 per share on revenues of $471.28 million. For the full year ending December 31, 2020, the company expects adjusted earnings of $2.47 to $2.62 per share and revenues in a range of $1.824 billion to $1.849 billion. Analysts expect earnings of $2.52 per share on revenues of $1.81 billion for the year.October 28, 2020
Spectrum Pharmaceuticals to Report Third Quarter 2020 Financial Results and Provide Corporate Update
Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the third quarter 2020 financial results and provide a corporate update on Wednesday, November 4, 2020 at 4:30 p.m. Eastern/1:30 p.m. Pacific. Conference Call and Webcast: Wednesday, November 4, 2020 @ 4:30 p.m. Eastern/1:30 p.m. Pacific Domestic: (877) 837-3910, Conference ID# 1281757 International: (973) 796-5077, Conference ID# 1281757 The conference call will also be available from the Investor Relations section of the company’s website at https://investor.sppirx.com/events-and-presentations and will be archived there shortly after the live event. About Spectrum Pharmaceuticals, Inc. Spectrum Pharmaceuticals is a biopharmaceutical company focused on acquiring, developing, and commercializing novel and targeted oncology therapies. Spectrum has a strong track record of successfully executing across the biopharmaceutical business model, from in-licensing and acquiring differentiated drugs, clinically developing novel assets, successfully gaining regulatory approvals and commercializing in a competitive healthcare marketplace. Spectrum has a late-stage pipeline with novel assets that serve areas of unmet need. This pipeline has the potential to transform the company in the near future.October 28, 2020
Apple’s launch promotional material of the New iPhone12 Pro seen displayed on a mobile phone screen with an Apple logo in the background. Pavlo Gonchar | LightRocket | Getty Images LONDON — Apple has quietly increased its efforts to develop its own search technology for iPhones, according to a report by The Financial Times (FT), as regulators scrutinize the multibillion-dollar payments that Google makes each year to ensure that its search engine is installed as a default search tool. When iPhone users with iOS 14, the latest iPhone software, type a query into the search window, Apple now shows its own search results instead of Google’s. It also displays auto-complete style suggestions, highlighting how it is learning from users most common search queries. However, few are likely to have noticed the change. The U.S. Department of Justice launched a case last week over payments that Google makes to Apple to be the iPhone’s default search tool. The DOJ cites “public estimates” saying that Google pays Apple between $8 billion and $12 billion per year to be the default search engine on Apple products. An in-house search offeringOctober 28, 2020
Worldwide Glucaric Acid Industry to 2026 – Featuring Rennovia, Rivertop Renewables & Kalion Among Others
Dublin, Oct. 28, 2020 (GLOBE NEWSWIRE) — The “Glucaric Acid Market, Size, Share, Outlook and COVID-19 Strategies, Global Forecasts from 2019 to 2026” report has been added to ResearchAndMarkets.com’s offering.As the Glucaric Acid industry shifts, the report presents the emerging market trends, factors driving the Glucaric Acid market growth, and potential opportunities over the forecast period. The trends underpinning the profitability of Glucaric Acid companies are shifting rapidly, forcing companies to carefully align their strengths in synchronization with Glucaric Acid industry trends.To avoid getting left behind in an intensive competitive Glucaric Acid market, global companies need a new approach to ensure they create value in this environment. Amid increasing activities of M&A and growing activist-investor activity, Glucaric Acid companies must strengthen their capabilities to maintain their market shares in the Glucaric Acid industry.The report presents an introduction to the Glucaric Acid market in 2020, analyzing the COVID-19 impact both quantitatively and qualitatively. It presents the strategies being adopted by leading Glucaric Acid companies, emerging market trends, Glucaric Acid market drivers, challenges, and potential opportunities to 2026. The market attractiveness index is also included to assess the impact of suppliers, buyers, competitive landscape, new entrants, and substitutes on the Glucaric AcidOctober 28, 2020